{"url_path":"/sec/ctor/8-k/2026-06-01/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1851484/0001213900-26-063530-index.html","accession_number":"0001213900-26-063530","cik":"0001851484","ticker":"CTOR","issuer_name":"CITIUS ONCOLOGY, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1851484/0001213900-26-063530-index.html","primary_entity_key":"0001851484","primary_entity_name":"CITIUS ONCOLOGY, INC."},"word_count":50,"has_tables":true,"body_markdown":"**Item\n8.01 Other Events.**\n\n** **\n\nOn\nJune 1, 2026, Citius Oncology, Inc. issued a press release announcing the presentation of clinical data at the Annual Meeting of the\nAmerican Society of Clinical Oncology. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K."}